Insider · CIK 0001337801

Scott Randal W.

CIK 0001337801 Name as filed on the most recent filing

Filed as Scott Randal W. (11)· Scott Randal W (69)

169 transaction lines · from 80 filings · filed 2007-02-14 to 2026-05-19 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

169 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-05-15 S, Open-market sale BridgeBio Pharma, Inc.BBIO 4 lines 671,456, disposed Open Form 4 filing 0001470831-26-000470
2026-02-17 S, Open-market sale BridgeBio Pharma, Inc.BBIO 3 lines 754,557, disposed Open Form 4 filing 0001470831-26-000182
2025-11-17 S, Open-market sale BridgeBio Pharma, Inc.BBIO 2 lines 666,465, disposed Open Form 4 filing 0001470831-25-000355
2024-06-04 S, Open-market sale BridgeBio Pharma, Inc.BBIO 46,950, disposed Open Form 4 filing 0000950170-24-069401
2024-06-03 S, Open-market sale BridgeBio Pharma, Inc.BBIO 2 lines 28,843, disposed Open Form 4 filing 0000950170-24-069401
2024-03-01 S, Open-market sale BridgeBio Pharma, Inc.BBIO 85,000, disposed Open Form 4 filing 0000950170-24-025839
2023-12-18 S, Open-market sale BridgeBio Pharma, Inc.BBIO 80,000, disposed Open Form 4 filing 0001209191-23-059324
2023-12-01 S, Open-market sale BridgeBio Pharma, Inc.BBIO 2 lines 73,500, disposed Open Form 4 filing 0001209191-23-057374
2023-09-05 S, Open-market sale BridgeBio Pharma, Inc.BBIO 75,000, disposed Open Form 4 filing 0001209191-23-048595
2021-05-17 P, Open-market purchase Talis Biomedical CorpTLIS 111,210, acquired Open Form 4 filing 0001209191-21-033441
2021-05-14 P, Open-market purchase Talis Biomedical CorpTLIS 91,440, acquired Open Form 4 filing 0001209191-21-033441
2021-02-17 P, Open-market purchase BridgeBio Pharma, Inc.BBIO 1,000,000, acquired Open Form 4 filing 0000899243-21-007172
2021-02-17 P, Open-market purchase Talis Biomedical CorpTLIS 5,000,000, acquired Open Form 4 filing 0001209191-21-012519
2019-08-26 S, Open-market sale Invitae CorpNVTA 2 lines 983,405, disposed Open Form 4 filing 0000899243-19-022539
2019-05-28 S, Open-market sale Invitae CorpNVTA 528,027, disposed Open Form 4 filing 0000899243-19-015216
2019-02-25 S, Open-market sale Invitae CorpNVTA 2 lines 572,997, disposed Open Form 4 filing 0000899243-19-004961
2018-04-02 P, Open-market purchase Invitae CorpNVTA 199,998, acquired Open Form 4 filing 0000899243-18-009049
2016-11-22 P, Open-market purchase Invitae CorpNVTA 399,996, acquired Open Form 4 filing 0000899243-16-034175
2012-07-11 S, Open-market sale Genomic Health IncGHDX 2 lines 522,134, disposed Open Form 4 filing 0001209191-12-037918
2012-07-10 S, Open-market sale Genomic Health IncGHDX 2 lines 539,537, disposed Open Form 4 filing 0001209191-12-037918
2012-06-12 S, Open-market sale Genomic Health IncGHDX 499,655, disposed Open Form 4 filing 0001209191-12-033663
2012-06-11 S, Open-market sale Genomic Health IncGHDX 2 lines 506,562, disposed Open Form 4 filing 0001209191-12-033663
2012-05-11 S, Open-market sale Genomic Health IncGHDX 3 lines 457,742, disposed Open Form 4 filing 0001209191-12-027992
2012-05-10 S, Open-market sale Genomic Health IncGHDX 2 lines 448,981, disposed Open Form 4 filing 0001209191-12-027992
2012-04-11 S, Open-market sale Genomic Health IncGHDX 283,790, disposed Open Form 4 filing 0001209191-12-022914
2012-04-10 S, Open-market sale Genomic Health IncGHDX 2 lines 288,081, disposed Open Form 4 filing 0001209191-12-022914
2012-03-13 S, Open-market sale Genomic Health IncGHDX 466,764, disposed Open Form 4 filing 0001209191-12-018139
2012-03-12 S, Open-market sale Genomic Health IncGHDX 464,681, disposed Open Form 4 filing 0001209191-12-018139
2012-02-10 S, Open-market sale Genomic Health IncGHDX 262,495, disposed Open Form 4 filing 0001209191-12-010167
2012-02-10 S, Open-market sale Genomic Health IncGHDX 262,495, disposed Open Form 4 filing 0001209191-12-009325
2012-02-09 S, Open-market sale Genomic Health IncGHDX 261,029, disposed Open Form 4 filing 0001209191-12-010167
2012-02-09 S, Open-market sale Genomic Health IncGHDX 261,029, disposed Open Form 4 filing 0001209191-12-009325
2012-01-11 S, Open-market sale Genomic Health IncGHDX 272,789, disposed Open Form 4 filing 0001209191-12-003433

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 6
  • Open-market sale 163
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Scott Randal W., insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001337801

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.